Adam Wysokiński

1.4k total citations
84 papers, 966 citations indexed

About

Adam Wysokiński is a scholar working on Psychiatry and Mental health, Physiology and Biological Psychiatry. According to data from OpenAlex, Adam Wysokiński has authored 84 papers receiving a total of 966 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Psychiatry and Mental health, 23 papers in Physiology and 17 papers in Biological Psychiatry. Recurrent topics in Adam Wysokiński's work include Diet and metabolism studies (17 papers), Schizophrenia research and treatment (17 papers) and Tryptophan and brain disorders (17 papers). Adam Wysokiński is often cited by papers focused on Diet and metabolism studies (17 papers), Schizophrenia research and treatment (17 papers) and Tryptophan and brain disorders (17 papers). Adam Wysokiński collaborates with scholars based in Poland, France and Germany. Adam Wysokiński's co-authors include Iwona Kłoszewska, Dominik Strzelecki, Tomasz Sobów, Tomasz Kostka, Elżbieta Kozłowska, Ewa Brzezińska‐Błaszczyk, Justyna Agier, Maciej Kowman, Aleksandra Piejka and Paulina Żelechowska and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Adam Wysokiński

77 papers receiving 952 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adam Wysokiński Poland 15 313 311 232 106 105 84 966
Dominik Strzelecki Poland 16 229 0.7× 281 0.9× 273 1.2× 152 1.4× 76 0.7× 102 947
Shinsuke Hidese Japan 19 193 0.6× 314 1.0× 175 0.8× 106 1.0× 116 1.1× 48 1.1k
Jerzy Landowski Poland 19 330 1.1× 187 0.6× 114 0.5× 81 0.8× 117 1.1× 90 895
Dong-Bin Cai China 21 443 1.4× 308 1.0× 69 0.3× 95 0.9× 92 0.9× 43 988
Fernanda Pedrotti Moreira Brazil 19 210 0.7× 329 1.1× 79 0.3× 116 1.1× 221 2.1× 60 963
Saliha Özsoy Türkiye 16 225 0.7× 97 0.3× 121 0.5× 83 0.8× 109 1.0× 47 796
Sebastian Rudolf Germany 21 270 0.9× 326 1.0× 209 0.9× 69 0.7× 246 2.3× 32 1.3k
Wolfgang Jordan Germany 17 232 0.7× 373 1.2× 241 1.0× 128 1.2× 197 1.9× 51 1.3k
Zachary A. Cordner United States 18 105 0.3× 120 0.4× 220 0.9× 126 1.2× 152 1.4× 31 933
Meihong Xiu China 18 509 1.6× 321 1.0× 141 0.6× 113 1.1× 107 1.0× 110 1.1k

Countries citing papers authored by Adam Wysokiński

Since Specialization
Citations

This map shows the geographic impact of Adam Wysokiński's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Wysokiński with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Wysokiński more than expected).

Fields of papers citing papers by Adam Wysokiński

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Wysokiński. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Wysokiński. The network helps show where Adam Wysokiński may publish in the future.

Co-authorship network of co-authors of Adam Wysokiński

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Wysokiński. A scholar is included among the top collaborators of Adam Wysokiński based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Wysokiński. Adam Wysokiński is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sochal, Marcin, Aleksandra Tarasiuk, Agata Binienda, et al.. (2024). Circadian Rhythm Genes and Their Association with Sleep and Sleep Restriction. International Journal of Molecular Sciences. 25(19). 10445–10445. 1 indexed citations
3.
Sochal, Marcin, Agata Binienda, Aleksandra Tarasiuk, et al.. (2024). The Relationship between Sleep Parameters Measured by Polysomnography and Selected Neurotrophic Factors. Journal of Clinical Medicine. 13(3). 893–893. 4 indexed citations
4.
Pawlak, Agnieszka, B Kaczmarek, Adam Wysokiński, & Dominik Strzelecki. (2023). Sarcosine May Induce EGF Production or Inhibit the Decline in EGF Concentrations in Patients with Chronic Schizophrenia (Results of the PULSAR Study). Pharmaceuticals. 16(11). 1557–1557. 2 indexed citations
5.
Wysokiński, Adam. (2023). TOLERABILITY AND SAFETY OF 219 TRANSCRANIAL DIRECT CURRENT STIMULATION (tDCS) 2.0 mA SESSIONS IN ADULT PATIENTS WITH SCHIZOPHRENIA. Psychiatria Danubina. 35(1). 33–37. 1 indexed citations
6.
Wysokiński, Adam, et al.. (2019). Fasting serum leptin levels in elderly women with major depressive disorder: a case-control study.. PubMed. 40(1). 51–57. 1 indexed citations
7.
Strzelecki, Dominik, et al.. (2018). Serum levels of interleukin 6 in schizophrenic patients during treatment augmentation with sarcosine (results of the PULSAR study). Human Psychopharmacology Clinical and Experimental. 33(2). e2652–e2652. 12 indexed citations
8.
Strzelecki, Dominik, et al.. (2018). Serum levels of TNF-alpha in patients with chronic schizophrenia during treatment augmentation with sarcosine (results of the PULSAR study). Psychiatry Research. 268. 447–453. 13 indexed citations
9.
Kozłowska, Elżbieta, Adam Wysokiński, & Ewa Brzezińska‐Błaszczyk. (2017). Serum levels of peptide cathelicidin LL-37 in elderly patients with depression. Psychiatry Research. 255. 156–160. 12 indexed citations
10.
Wysokiński, Adam, et al.. (2016). Platelet parameters (PLT, MPV, P-LCR) in patients with schizophrenia, unipolar depression and bipolar disorder. Psychiatry Research. 237. 238–245. 42 indexed citations
11.
Wysokiński, Adam & Tomasz Sobów. (2016). Vortioxetine – an antidepressant with a multifunctional mechanism of action. Psychiatria i Psychologia Kliniczna. 16(2). 99–103. 1 indexed citations
12.
Wysokiński, Adam, Dominik Strzelecki, & Iwona Kłoszewska. (2015). Levels of triglycerides, cholesterol, LDL, HDL and glucose in patients with schizophrenia, unipolar depression and bipolar disorder. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 9(3). 168–176. 95 indexed citations
13.
Wysokiński, Adam & Iwona Kłoszewska. (2015). Uric acid levels in patients with schizophrenia on clozapine monotherapy. Nordic Journal of Psychiatry. 69(6). 1735–1740. 5 indexed citations
14.
Wysokiński, Adam, et al.. (2014). Levels of C-reactive protein (CRP) in patients with schizophrenia, unipolar depression and bipolar disorder. Nordic Journal of Psychiatry. 69(5). 346–353. 78 indexed citations
15.
Wysokiński, Adam & Iwona Kłoszewska. (2013). Wilazodon — nowy wielofunkcyjny lek przeciwdepresyjny. Psychiatria. 10(2). 72–75. 2 indexed citations
16.
Wysokiński, Adam, et al.. (2013). Effect of metabolic abnormalities on cognitive performance and clinical symptoms in schizophrenia. Archives of Psychiatry and Psychotherapy. 15(4). 13–25. 11 indexed citations
17.
Wysokiński, Adam & Iwona Kłoszewska. (2012). Review article The role of genetic polymorphisms in antipsychotic-induced metabolic disorders. 6(3). 120–141.
18.
Wysokiński, Adam & Iwona Kłoszewska. (2011). Zespół metaboliczny i zaburzenia depresyjne — przegląd piśmiennictwa. Psychiatria. 8(2). 46–52. 1 indexed citations
19.
Orzechowska, Agata, Antoni Florkowski, Wojciech Gruszczyński, et al.. (2009). [Socio-economic status, aggressive behaviours and coping with stress].. PubMed. 43(1). 53–63. 8 indexed citations
20.
Wysokiński, Adam, et al.. (2008). Zaburzenia depresyjne i lękowe w okresie klimakterium. Psychiatria. 5(3). 99–103. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dominik Strzelecki Breakdown of academic impact, for papers by Shinsuke Hidese Breakdown of academic impact, for papers by Jerzy Landowski Breakdown of academic impact, for papers by Dong-Bin Cai Breakdown of academic impact, for papers by Fernanda Pedrotti Moreira Breakdown of academic impact, for papers by Saliha Özsoy Breakdown of academic impact, for papers by Sebastian Rudolf Breakdown of academic impact, for papers by Wolfgang Jordan Breakdown of academic impact, for papers by Zachary A. Cordner Breakdown of academic impact, for papers by Meihong Xiu
Rankless by CCL
2026